The 2024 conference has 28 late-breakers plus plenty of basic and population science. More than anything, it’s a celebration.

In high- and standard-risk patients CAS and TCAR look good, but some worry about skill sets, learning curves, and ...

The latest version of the LLM had high concordance with a multidisciplinary heart team in choosing between PCI and CABG.

Ami Bhatt asks Kate Dalton to share details on the challenges of early feasibility studies from her perspective as a clinical site coordinator.

Ami Bhatt and Michael Mack explain the economics of AI use in the detection of subclinical cardiovascular disease.

In addition to ensuring equitable access to the glucagon-like peptide-1 (GLP-1) receptor agonists, the medical community ...

While statins can reduce LDL levels and ASCVD events, high Lp(a) poses an independent risk that will need attention, too.

There’s no “silver bullet” for this problem, which is largely driven by clinical inertia, but some efforts are chipping away ...

Private equity is taking on a much larger role within cardiology, the 12th annual cardiovascular provider compensation and ...

Just 15% of patients have their filters taken out despite clear recommendations they should be removed as soon as feasible.

The results in patients with long, complex lesions are better than or equal to those of surgery, but without the ...

Women who experience hypertensive disorders of pregnancy (HDP) go on to develop CAD earlier in life compared with women who ...